These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8522248)

  • 1. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
    Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
    Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
    Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
    Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.
    Rosen A; Sevelda P; Klein M; Dobianer K; Hruza C; Czerwenka K; Hanak H; Vavra N; Salzer H; Leodolter S
    Br J Cancer; 1993 May; 67(5):1122-5. PubMed ID: 8494710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
    Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
    Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment.
    Berns EM; Foekens JA; van Staveren IL; van Putten WL; de Koning HY; Portengen H; Klijn JG
    Gene; 1995 Jun; 159(1):11-8. PubMed ID: 7607564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.
    Dobianer K; Hruza C; Ehrlich G; Sevelda P; Czerwenka K; Soreq H; Spona J; Zakut H
    Gynecol Oncol; 1995 Feb; 56(2):200-6. PubMed ID: 7896186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene amplification per se: an independent prognostic factor in human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mol Carcinog; 1994 Dec; 11(4):189-91. PubMed ID: 7999260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
    Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
    Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.
    Ross JS; Yang F; Kallakury BV; Sheehan CE; Ambros RA; Muraca PJ
    Am J Clin Pathol; 1999 Mar; 111(3):311-6. PubMed ID: 10078105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis.
    Rubin SC; Finstad CL; Wong GY; Almadrones L; Plante M; Lloyd KO
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):162-9. PubMed ID: 8093588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplifications in advanced-stage human prostate cancer.
    Fournier G; Latil A; Amet Y; Abalain JH; Volant A; Mangin P; Floch HH; Lidereau R
    Urol Res; 1995; 22(6):343-7. PubMed ID: 7740653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.
    Berns EM; Klijn JG; van Staveren IL; Portengen H; Noordegraaf E; Foekens JA
    Eur J Cancer; 1992; 28(2-3):697-700. PubMed ID: 1350457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the Int-2 gene in head and neck squamous cell carcinoma.
    Rubin JS; Qiu L; Etkind P
    J Laryngol Otol; 1995 Jan; 109(1):72-6. PubMed ID: 7876747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.
    Ross JS; Sheehan C; Hayner-Buchan AM; Ambros RA; Kallakury BV; Kaufman R; Fisher HA; Muraca PJ
    Hum Pathol; 1997 Jul; 28(7):827-33. PubMed ID: 9224752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
    An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
    Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene amplifications in early-stage human prostate carcinomas.
    Latil A; Baron JC; Cussenot O; Fournier G; Boccon-Gibod L; Le Duc A; Lidereau R
    Int J Cancer; 1994 Dec; 59(5):637-8. PubMed ID: 7960236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.